Del Mar Pharmaceuticals Inc. filed its 8-K on Jan 31, 2013 for the period ending Dec 31, 2011. In this report its auditor, PricewaterhouseCoopers LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.